Therefore, the lack of Cbl in the MS CNS seems to impinge only on myelin damage and remyelination failure; therefore, the possibility that SC Cbl deficiency may be a contributory factor in the immunological abnormalities of MS remains merely speculative. The gene discussed is CBL; the disease is myeloid sarcoma.